Skip to main content

Page of 9
and
  1. Article

    Open Access

    SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy

    Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different ex...

    Maria Teresa Sandri, Elena Azzolini, Valter Torri, Sara Carloni in Scientific Reports (2021)

  2. No Access

    Article

    Tumor-associated myeloid cells: diversity and therapeutic targeting

    Myeloid cells in tumor tissues constitute a dynamic immune population characterized by a non-uniform phenotype and diverse functional activities. Both tumor-associated macrophages (TAMs), which are more abunda...

    Alberto Mantovani, Federica Marchesi, Sebastien Jaillon in Cellular & Molecular Immunology (2021)

  3. Article

    Author Correction: A guiding map for inflammation

    A Correction to this paper has been published: https://doi.org/10.1038/ni.3790

    Mihai G. Netea, Frances Balkwill, Michel Chonchol, Fabio Cominelli in Nature Immunology (2021)

  4. Article

    COVID-19 vaccines: where we stand and challenges ahead

    In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects. Over 40 ...

    Guido Forni, Alberto Mantovani in Cell Death & Differentiation (2021)

  5. No Access

    Article

    Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression

    Complement has emerged as a component of tumor-promoting inflammation. We conducted a systematic assessment of the role of complement activation and effector pathways in sarcomas. C3−/−, MBL1/2−/− and C4−/− mice ...

    Elena Magrini, Sabrina Di Marco, Sarah N. Mapelli, Chiara Perucchini in Nature Cancer (2021)

  6. No Access

    Chapter

    Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T-Cells in Cancer Immunotherapy

    Immunotherapy based on adoptive T-cell transfer provides a promising form of cancer therapy, but often fails to induce long-lasting responses in the great majority of patients. During the past few decades, sev...

    Imran Siddiqui, Debora Vignali, Marinos Kallikourdis in Cancer Immunology (2021)

  7. Article

    Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

    Long pentraxin 3 (PTX3) is an essential component of humoral innate immunity, involved in resistance to selected pathogens and in the regulation of inflammation13. The present study was designed to assess the pr...

    Enrico Brunetta, Marco Folci, Barbara Bottazzi, Maria De Santis in Nature Immunology (2021)

  8. No Access

    Article

    The other side of the innate immune system: humoral arms favoring cancer

    Cancer cells take advantage of NETosis to escape host immune surveillance and mediate metastasis. The pharmacological targeting of NETosis may prove beneficial in maximizing the response to cancer immunotherapy.

    Maria De Santis, Alberto Mantovani, Carlo Selmi in Cellular & Molecular Immunology (2020)

  9. No Access

    Article

    Neutrophil diversity and plasticity in tumour progression and therapy

    Neutrophils play a key role in defence against infection and in the activation and regulation of innate and adaptive immunity. In cancer, tumour-associated neutrophils (TANs) have emerged as an important compo...

    Sebastien Jaillon, Andrea Ponzetta, Diletta Di Mitri in Nature Reviews Cancer (2020)

  10. Article

    Ten things we learned about COVID-19

    Maurizio Cecconi, Guido Forni, Alberto Mantovani in Intensive Care Medicine (2020)

  11. No Access

    Article

    Determination of pentraxin 3 levels in cerebrospinal fluid during central nervous system infections

    Pentraxin 3 (PTX3) is an acute phase protein; its plasmatic levels significantly rise during severe infections. Data on PTX3 levels in cerebrospinal fluid (CSF) of patients with central nervous system (CNS) in...

    Marta Zatta, Stefano Di Bella in European Journal of Clinical Microbiology … (2020)

  12. No Access

    Chapter

    Tumor-Associated Myeloid Cells in Cancer Progression

    The tumor microenvironment plays a pivotal role in orchestrating tumor initiation, progression, and spreading, as well as response to therapy. Myeloid immune cells infiltrating tumors are integral component of...

    Tamara Gulic, Rita Silva-Gomes, Sadaf Davoudian, Marina Sironi in Cancer Immunology (2020)

  13. Article

    Open Access

    Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium

    Biomarkers predictive of inflammatory events post-vaccination could accelerate vaccine development. Within the BIOVACSAFE framework, we conducted three identically designed, placebo-controlled inpatient/outpat...

    January Weiner, David J. M. Lewis, Jeroen Maertzdorf in Scientific Reports (2019)

  14. Article

    Chronic inflammation in the etiology of disease across the life span

    Although intermittent increases in inflammation are critical for survival during physical injury and infection, recent research has revealed that certain social, environmental and lifestyle factors can promote...

    David Furman, Judith Campisi, Eric Verdin, Pedro Carrera-Bastos in Nature Medicine (2019)

  15. No Access

    Article

    ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability, data transparency and validation through the scientific peer-review process.

    Dimitrios C. Mastellos, Anna M. Blom, E. Sander Connolly in Nature Immunology (2019)

  16. Article

    Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Dimitrios C. Mastellos, Anna M. Blom, E. Sander Connolly in Nature Immunology (2019)

  17. Article

    Open Access

    The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018

    As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy tod...

    Paolo A. Ascierto, Lisa H. Butterfield in Journal for ImmunoTherapy of Cancer (2019)

  18. No Access

    Article

    The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell–mediated resistance to metastasis

    The plasma membrane tetraspan molecule MS4A4A is selectively expressed by macrophage-lineage cells, but its function is unknown. Here we report that MS4A4A was restricted to murine and human mononuclear phagoc...

    Irene Mattiola, Federica Tomay, Maria De Pizzol, Rita Silva-Gomes in Nature Immunology (2019)

  19. Article

    Open Access

    Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points

    This publication summarizes discussions that were held during an international expert hearing organized by the German Federal Institute for Risk Assessment (BfR) in Berlin, Germany, in October 2017. The expert...

    Olena Kucheryavenko, Glenn Lurman, Anja Lehmann, Juliana Braz in Archives of Toxicology (2019)

  20. Article

    Open Access

    The Ramazzini Institute 13-week pilot study glyphosate-based herbicides administered at human-equivalent dose to Sprague Dawley rats: effects on development and endocrine system

    Glyphosate-based herbicides (GBHs) are broad-spectrum herbicides that act on the shikimate pathway in bacteria, fungi, and plants. The possible effects of GBHs on human health are the subject of an intense pub...

    Fabiana Manservisi, Corina Lesseur, Simona Panzacchi in Environmental Health (2019)

Page of 9